Designing plans to manage comorbid conditions
Health plans that address and manage complex chronic conditions such as cardiovascular disease, obesity, and diabetes have a competitive advantage.
Read MoreClinically Speaking: Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreAddressing obesity in the workplace
As more people turn to diabetes medication to manage their weight, obesity has become a pressing concern for employers.
Read MoreWhy is prenatal care vital to a happy and healthy pregnancy?
Pregnant individuals require routine, dedicated care to ensure positive parental and fetal outcomes.
Read MoreExploring common misconceptions about male and female infertility
Education is a key first step toward providing vital and holistic fertility coverage.
Read MoreExpress Scripts launches new initiative to expand rural health care access through partnerships with independent pharmacies
Express Scripts announced key efforts to expand access to health care in rural communities through partnerships with independent pharmacies across the U.S.
Read MoreExpress Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read More2023 Health Care Trends
Hybrid care models, affordability, health equity, and behavioral health emerge as top focus areas for plan sponsors and consumers.
Read More